AGs Question FDA Plan for Mail-Back Opioid Program

Cozen O'Connor
Contact
LinkedIn
Facebook
X
Send
Embed

Cozen O'Connor

  • 13 Republican AGs wrote a letter to the FDA in response to its Request for Information regarding “In-Home Disposal Systems for Opioid Analgesics,” a proposed mail-back program for leftover opioid products.
  • In the letter, the AGs voiced their concerns that a mail-back program for unused opioids would provide opportunities for drug misuse and diversion, increase the amount of illicit substances in the mail at a time when law enforcement is working to curb the use of the USPS for fentanyl sales, and would be inconvenient for rural Americans.
  • The AGs ask the FDA to ensure that its response to leftover opioids also includes an option that allows consumers to choose in-home single use drug disposal products.
Send Print Report

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Cozen O'Connor | Attorney Advertising

Written by:

Cozen O'Connor
Cozen O'Connor
Contact
more
less

Cozen O'Connor on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign Up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide